Mechanistic and evolutionary insights into a type V-M CRISPR–Cas effector enzyme

被引:0
|
作者
Satoshi N. Omura
Ryoya Nakagawa
Christian Südfeld
Ricardo Villegas Warren
Wen Y. Wu
Hisato Hirano
Charlie Laffeber
Tsukasa Kusakizako
Yoshiaki Kise
Joyce H. G. Lebbink
Yuzuru Itoh
John van der Oost
Osamu Nureki
机构
[1] the University of Tokyo,Department of Biological Sciences, Graduate School of Science
[2] Wageningen University and Research,Laboratory of Microbiology
[3] Oncode Institute,Department of Molecular Genetics
[4] Erasmus MC Cancer Institute,Curreio
[5] Erasmus University Medical Center,Department of Radiotherapy
[6] the University of Tokyo,undefined
[7] Erasmus University Medical Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
RNA-guided type V CRISPR–Cas12 effectors provide adaptive immunity against mobile genetic elements (MGEs) in bacteria and archaea. Among diverse Cas12 enzymes, the recently identified Cas12m2 (CRISPR–Cas type V-M) is highly compact and has a unique RuvC active site. Although the non-canonical RuvC triad does not permit dsDNA cleavage, Cas12m2 still protects against invading MGEs through transcriptional silencing by strong DNA binding. However, the molecular mechanism of RNA-guided genome inactivation by Cas12m2 remains unknown. Here we report cryo-electron microscopy structures of two states of Cas12m2–CRISPR RNA (crRNA)–target DNA ternary complexes and the Cas12m2–crRNA binary complex, revealing structural dynamics during crRNA–target DNA heteroduplex formation. The structures indicate that the non-target DNA strand is tightly bound to a unique arginine-rich cluster in the recognition (REC) domains and the non-canonical active site in the RuvC domain, ensuring strong DNA-binding affinity of Cas12m2. Furthermore, a structural comparison of Cas12m2 with TnpB, a putative ancestor of Cas12 enzymes, suggests that the interaction of the characteristic coiled-coil REC2 insertion with the protospacer-adjacent motif-distal region of the heteroduplex is crucial for Cas12m2 to engage in adaptive immunity. Collectively, our findings improve mechanistic understanding of diverse type V CRISPR–Cas effectors and provide insights into the evolution of TnpB to Cas12 enzymes.
引用
收藏
页码:1172 / 1182
页数:10
相关论文
共 50 条
  • [31] Disruption of Aberrant Splicing of STMN2 by Gene Editing with a Type V CRISPR-Cas Enzyme as a Potential Treatment for ALS
    Negraes, Priscilla D.
    Buckett, Peter D.
    Jones-Tabah, Jace
    Garrity, Anthony J.
    Bose, Mishti
    Lule, Sevda
    Park, Andrew
    Sheppard, Nolan
    Truong, Linh B.
    Yang, Qiyuan
    Kristanto, Ivan A.
    Presa, Maximiliano F.
    Ryan, Jennifer
    Merkel, Erin
    Noe, Christina
    Tobin, Jenny V.
    Liu, Lijun
    Borel, Florie
    Lutz, Cathleen
    Murphy, John E.
    Chung, Chee Yeun
    MOLECULAR THERAPY, 2024, 32 (04) : 746 - 746
  • [32] Mechanistic insights of CRISPR/Cas-mediated genome editing towards enhancing abiotic stress tolerance in plants
    Bhat, Mujtaba Aamir
    Mir, Rakeeb Ahmad
    Kumar, Vijay
    Shah, Ali Asghar
    Zargar, Sajad Majeed
    Rahman, Safikur
    Jan, Arif Tasleem
    PHYSIOLOGIA PLANTARUM, 2021, 172 (02) : 1255 - 1268
  • [33] Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation
    Huo, Yanwu
    Nam, Ki Hyun
    Ding, Fang
    Lee, Heejin
    Wu, Lijie
    Xiao, Yibei
    Farchione, M. Daniel, Jr.
    Zhou, Sharleen
    Rajashankar, Kanagalaghatta
    Kurinov, Igor
    Zhang, Rongguang
    Ke, Ailong
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2014, 21 (09) : 771 - 777
  • [34] Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation
    Yanwu Huo
    Ki Hyun Nam
    Fang Ding
    Heejin Lee
    Lijie Wu
    Yibei Xiao
    M Daniel Farchione
    Sharleen Zhou
    Kanagalaghatta Rajashankar
    Igor Kurinov
    Rongguang Zhang
    Ailong Ke
    Nature Structural & Molecular Biology, 2014, 21 : 771 - 777
  • [35] On the Origin and Evolutionary Relationships of the Reverse Transcriptases Associated With Type III CRISPR-Cas Systems
    Toro, Nicolas
    Martinez-Abarca, Francisco
    Gonzalez-Delgado, Alejandro
    Rodriguez Mestre, Mario
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [36] Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19
    Kwon, Sangha
    Shin, Ha Youn
    LIFE-BASEL, 2021, 11 (12):
  • [37] Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types
    Wu, Wen Y.
    Jackson, Simon A.
    Almendros, Cristobal
    Haagsma, Anna C.
    Yilmaz, Suzan
    Gort, Gerrit
    van der Oost, John
    Brouns, Stan J. J.
    Staals, Raymond H. J.
    CRISPR JOURNAL, 2022, 5 (04): : 536 - 547
  • [38] Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins
    Yang, Lingguang
    Zhang, Yi
    Yin, Peipei
    Feng, Yue
    RNA BIOLOGY, 2021, 18 : 562 - 573
  • [39] Evolution of Type IV CRISPR-Cas Systems: Insights from CRISPR Loci in Integrative Conjugative Elements of Acidithiobacillia
    Moya-Beltran, Ana
    Makarova, Kira S.
    Acuna, Lillian G.
    Wolf, Yuri, I
    Covarrubias, Paulo C.
    Shmakov, Sergey A.
    Silva, Cristian
    Tolstoy, Igor
    Johnson, D. Barrie
    Koonin, Eugene, V
    Quatrini, Raquel
    CRISPR JOURNAL, 2021, 4 (05): : 656 - 672
  • [40] Discovery and Engineering of a Miniature CRISPR-Cas Type V-L System
    Alfonse, Lauren E.
    Ornstein, Alexa
    Doherty, Erin
    Rachman, Jenna M.
    Sasaki, Tomoaki
    McMahon, Blake
    Wessells, Quinton
    Garrity, Anthony J.
    Munoz, Gabrielle Z.
    Maben, Zachary
    Bose, Mishti
    Yan, Paul
    Biasella, Amy
    Cheng, David R.
    DiTommaso, Tia
    Murphy, John E.
    Hoffman, Gregory R.
    MOLECULAR THERAPY, 2023, 31 (04) : 271 - 271